Malta - inglês - Medicines Authority

glaxosmithkline export limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - chlorphenamine maleate, paracetamol, pseudoephedrine hydrochloride - tablet - chlorphenamine maleate 2 mg paracetamol 500 mg pseudoephedrine hydrochloride 30 mg - analgesics

Malta - inglês - Medicines Authority

glaxosmithkline export limited - paracetamol 500 mg, pseudoephedrine hydrochloride 30 mg - film-coated tablet

Malta - inglês - Medicines Authority

glaxosmithkline export limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - paracetamol, pseudoephedrine hydrochloride - tablet - paracetamol 500 mg pseudoephedrine hydrochloride 30 mg - analgesics

União Europeia - inglês - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - ambrisentan 10mg - tablet - 10 mg - active: ambrisentan 10mg excipient: croscarmellose sodium opadry ii red 85g94101 lactose magnesium stearate microcrystalline cellulose - volibris is indicated for the treatment of: · idiopathic pulmonary arterial hypertension (pah) · pulmonary arterial hypertension associated with connective tissue disease (pah-ctd) in patients with who functional class ii, iii or iv symptoms.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - ambrisentan 5mg - tablet - 5 mg - active: ambrisentan 5mg excipient: croscarmellose sodium opadry ii pink 85g94065 lactose magnesium stearate microcrystalline cellulose - volibris is indicated for the treatment of: · idiopathic pulmonary arterial hypertension (pah) · pulmonary arterial hypertension associated with connective tissue disease (pah-ctd) in patients with who functional class ii, iii or iv symptoms.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - abacavir sulfate 702mg equivalent to abacavir 600 mg;  ; dolutegravir sodium 52.6mg equivalent to dolutegravir 50 mg;  ;  ;  ; lamivudine 300mg;   - film coated tablet - 50mg/600mg/300mg - active: abacavir sulfate 702mg equivalent to abacavir 600 mg   dolutegravir sodium 52.6mg equivalent to dolutegravir 50 mg       lamivudine 300mg   excipient: magnesium stearate mannitol microcrystalline cellulose opadry purple 85f90057 povidone sodium starch glycolate - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-na?ve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in triumeq.

União Europeia - inglês - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.

União Europeia - inglês - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hypertension, pulmonary - antihypertensives, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.1).  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.1).

União Europeia - inglês - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastic agents - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy., as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.